Latest:
Americans Say Drug Costs Are Too High, and They Are Right
The executive director of the Biosimilars Forum calls for policies to support adoption of lower-cost biologics.
© 2022 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Latest:
Column: India Struggles to Meet International Biologics Standards
Latest:
Opinion: Biosimilars Offer Savings and Access for US Patients
Latest:
Biosimilars and Women's Health: Realizing the Potential
Latest:
Opinion: Support Health Equity and Access to Health Care With More Affordable Treatment Options
Latest:
What We Learned About Biologics on Summer Vacation
Latest:
Opinion: Embrace the Era of Next-Generation Biologics
Latest:
Making Patients in Canada Switch to Etanercept Biosimilars Caused No Harm or Changes in Health Care Use, Study Finds